Valuation: Bayer AG

Market Cap 47.12B 52.6B 43.47B 39.34B 73.56B 5,009B 74.74B 519B 207B 2,622B 197B 193B 8,303B P/E 2026 *
20.3x
P/E 2027 * 15.2x
Enterprise Value 76.79B 85.73B 70.84B 64.11B 120B 8,164B 122B 845B 337B 4,273B 322B 315B 13,532B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.56x
Free-Float
99.99%
Yield 2026 *
0.29%
Yield 2027 * 1.16%
1 day+4.48%
1 week+8.48%
Current month+0.02%
1 month-1.88%
3 months+0.57%
6 months+31.58%
Current year+29.59%
1 week 44.51
Extreme 44.51
47.96
1 month 42.56
Extreme 42.56
47.96
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 65 26/04/2024
Director/Board Member 70 01/04/2021
Director/Board Member 65 01/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
18/3/26 Buy

Director

1,900 0.0002%
18/3/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/3/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+4.42%+8.48%+74.02%+18.39% 52.6B
+6.63%+5.13%+68.86%+145.20% 1,224B
+1.53%+2.84%+47.48%+89.01% 662B
+1.68%+1.96%+29.16%+109.31% 514B
+0.68%+3.63%+54.80%+67.88% 388B
+3.83%-0.62%+69.01%+42.32% 361B
+0.93%+4.55%+35.34%+58.12% 302B
+3.51%+4.71%+7.03%+31.42% 271B
+1.97%+3.01%+57.91%+76.14% 249B
+4.03%+5.36%+39.76%+116.14% 205B
Average +2.51%+3.18%+48.34%+75.39% 422.94B
Weighted average by Cap. +2.25%+3.11%+51.06%+95.59%

Financials

2026 *2027 *
Net sales 45.87B 51.21B 42.32B 38.29B 71.61B 4,877B 72.76B 505B 201B 2,552B 192B 188B 8,083B 47.05B 52.53B 43.41B 39.28B 73.45B 5,002B 74.64B 518B 207B 2,618B 197B 193B 8,292B
Net income 2.3B 2.56B 2.12B 1.92B 3.59B 244B 3.64B 25.28B 10.09B 128B 9.62B 9.42B 405B 3.02B 3.38B 2.79B 2.52B 4.72B 322B 4.8B 33.29B 13.28B 168B 12.67B 12.4B 533B
Net Debt 29.67B 33.13B 27.37B 24.77B 46.32B 3,155B 47.07B 327B 130B 1,651B 124B 122B 5,229B 26.44B 29.51B 24.39B 22.07B 41.27B 2,811B 41.94B 291B 116B 1,471B 111B 108B 4,659B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
30/10/26 EUR 50.46 +5.21% 353,184
29/10/26 EUR 47.96 +4.19% 2,660,395
28/10/26 EUR 46.03 -0.26% 1,786,980
27/10/26 EUR 46.15 +1.29% 1,801,210
26/10/26 EUR 45.56 +3.59% 1,964,992
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.96EUR
Average target price
58.33EUR
Spread / Average Target
+21.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock